Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients

Vaccine. 2021 Mar 30:S0264-410X(21)00402-3. doi: 10.1016/j.vaccine.2021.03.086. Online ahead of print.NO ABSTRACTPMID:33824042 | DOI:10.1016/j.vaccine.2021.03.086

Source: Vaccine - April 7, 2021 Category: Allergy & Immunology Authors: Lorenzo Azzi Daniele Focosi Francesco Dentali Andreina Baj Fabrizio Maggi Source Type: research